Case Commentary: Dual ß-lactam as part of regimen to treat Mycobacterium abscessus lung disease.
Antimicrob Agents Chemother
; 68(7): e0058524, 2024 Jul 09.
Article
em En
| MEDLINE
| ID: mdl-38837394
ABSTRACT
Individuals with compromised lung function and immunity are susceptible to developing chronic Mycobacterium abscessus infection. Current treatment recommendations typically involve using one ß-lactam antibiotic in combination with non-ß-lactam antibiotics. However, a recent case study (B. Becken, K. M. Dousa, J. L. Johnson, S. M. Holland, and R. A. Bonomo, Antimicrob Agents Chemother 68e00319-24, 2024, https//doi.org/10.1128/aac.00319-24) demonstrated successful treatment of chronic M. abscessus lung disease in a child using two ß-lactam antibiotics simultaneously. This commentary reviews the emerging evidence and outstanding questions regarding dual ß-lactam therapy for M. abscessus infections.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Beta-Lactamas
/
Mycobacterium abscessus
/
Pneumopatias
/
Antibacterianos
/
Infecções por Mycobacterium não Tuberculosas
Limite:
Child
/
Humans
Idioma:
En
Revista:
Antimicrob Agents Chemother
Ano de publicação:
2024
Tipo de documento:
Article